FDA Inspection 1262891 — Naveen Sankhyan, MD
The FDA completed an inspection of Naveen Sankhyan, MD on Jan 23, 2025 in Chandigarh. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 23, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chandigarh (India)
Additional Details
Clinical Investigator (CI)